M

    MetaVia Inc. (MTVA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.72
    +0.02 (+1.18%)

    Market Cap: $11.20M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(17/34)
    Avg Surprise
    -540.94%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.73
    Range$-0.94 - $-0.33
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.96-30.9%
    60d ago$-0.75-1.8%
    30d ago$-0.75-1.8%
    7d ago$-0.74-0.5%
    Current$-0.73
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Dec 31, 2026
    EPS Consensus$-0.21
    Range$-1.30 - $0.34
    3 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.21---
    Sep 26EST
    		-$-0.73---
    Jun 26
    		$-0.90$-0.85-5.88%Miss-246.2%
    Mar 26
    		$-0.79$-0.75-5.33%Miss-119.4%
    Dec 25
    		$N/A$-1.82N/ABeat-
    Sep 25
    		$-1.54$-2.75+44.00%Beat+74.5%
    Jun 25
    		$-0.26$-0.32+18.75%Beat+98.7%
    Mar 25
    		$-0.36$-0.30-20.00%Miss+72.7%
    Dec 24
    		$-3.52N/A+56.76%Beat+86.0%
    Sep 24
    		$-6.05$-8.03+24.66%Beat+23.6%
    Jun 24
    		$-20.35$-12.36-64.64%Miss-1056.3%
    Mar 24
    		$-1.32N/A+63.64%Beat+75.0%
    Dec 23
    		$-25.08$-8.63-190.61%Miss-608.7%
    Sep 23
    		$-7.92$-9.68+18.18%Beat+97.4%
    Jun 23
    		$-1.76N/A+84.62%Beat-1366.7%
    Mar 23
    		$-5.28N/A+90.48%Beat-3005.9%
    Dec 22
    		$4.93$-1.20+510.83%Beat+101.2%
    Sep 22
    		$-308.00$-448.80+31.37%Beat+35.2%
    Jun 22
    		$-0.12N/A+97.65%Beat+100.0%
    Mar 22
    		$-0.17$-0.16-6.25%Miss+100.0%
    Sep 21
    		$-422.40$-475.20+11.11%Beat-6.7%
    Jun 21
    		$-475.20$-396.00-20.00%Miss+40.0%
    Mar 21
    		$-3168.00$-501.60-531.58%Miss-433872.6%
    Sep 20
    		$-501.60$-448.80-11.76%Miss-8260.0%
    Jun 20
    		$-396.00$-712.80+44.44%Beat-7820.0%
    Mar 20
    		$-792.00$-264.00-200.00%Miss-11633.3%
    Dec 19
    		$-0.73N/A+67.56%Beat+88.8%
    Sep 19
    		$-6.00$-0.11-5354.55%Miss+44.2%
    Jun 19
    		$-5.00$-0.12-4066.67%Miss+57.4%
    Mar 19
    		$-6.75$-0.42-1507.14%Miss+53.4%
    Dec 18
    		$-6.50$-0.41-1485.37%Miss-931.7%
    Sep 18
    		$-10.75$-0.47-2187.23%Miss-1606.3%
    Jun 18
    		$-11.75$-0.55-2036.36%Miss-1466.7%
    Mar 18
    		$-14.50$-0.67-2064.18%Miss+99.7%
    Dec 17
    		$-0.63$-0.69+8.70%Beat+100.0%
    Sep 17
    		$-0.63N/A+96.31%Beat+100.0%
    Jun 17
    		$-0.75N/A+96.59%Beat-
    Mar 17
    		$-4723.76N/AN/ABeat-
    Dec 16
    		$-4672.28N/AN/ABeat-
    Sep 16
    		$-3389.34N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.49EV/EBITDA-0.44x
    Price/FCF-0.64xFCF Yield-155.20%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-175.70%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage37.66x
    Current Ratio2.06xQuick Ratio2.06x
    Trading Statistics
    Beta0.90Avg Volume75.64K
    52-Week High$19.0352-Week Low$0.97

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.58
    SMA 20$1.52
    SMA 50$1.56
    SMA 200$3.15
    EMA 10$1.61
    EMA 20$1.57
    EMA 50$1.62
    EMA 200$3.39

    MACD

    Line: 0.03Signal: -0.01Hist: 0.04

    ADX

    ADX: 30.2+DI: 33.1-DI: 9.3

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down16.0
    PSAR$1.46

    Bollinger Bands

    Upper Band$1.72
    Lower Band$1.33
    %B Position2576%(Upper)
    Band Width1.01

    RSI (14-Day)

    Neutral
    64.1

    Momentum Oscillators

    Stoch %K72.0
    Stoch %D67.9
    Williams %R-21.0
    ROC (10d)16.2%
    Momentum0.24
    CCI (20d)163.2
    MFI (14d)67.3

    Volatility Measures

    ATR (14d)$0.10(6.1%)
    StdDev (20d)0.10
    Hist Vol43.1%(High)

    Volume Flow

    VWAP$1.71
    OBV265.4M
    AD Line16.5B
    CMF (20d)-0.150

    Volume Metrics

    Avg Vol (20d)77.7K
    Vol Ratio0.3x(Low)
    VWMA (20d)$1.52

    Pivot Points

    R3$1.79
    R2$1.76
    R1$1.73
    Pivot Point$1.70
    S1$1.67
    S2$1.64
    S3$1.61

    Advanced Oscillators

    TSI8.94
    Ultimate Osc54.1
    KST18.78

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$5,000$0$0$0$9,000$0$0$0$4,000$0
    Gross Profit$0$0$-5,000$0$0$0$-9,000$0$0$0$-4,000$0
    Operating Expenses$5.38M$4.03M$2.05M$3.48M$4.30M$3.89M$5.58M$6.26M$10.08M$6.88M$5.67M$3.89M
    R&D$3.48M$2.10M$241,000$1.91M$2.32M$2.33M$4.06M$4.52M$8.07M$4.90M$3.87M$2.29M
    SG&A$1.91M$1.92M$1.80M$1.56M$1.98M$1.56M$1.53M$1.74M$2.01M$1.98M$1.80M$1.60M
    Operating Income$-5,385,000$-4,025,000$-2,046,000$-3,475,000$-4,301,000$-3,886,000$-5,585,000$-6,259,000$-10,084,000$-6,881,000$-5,667,000$-3,893,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$-73,000$-85,000$-85,000$-151,000$-146,000$-128,000$-209,000$-310,000$-164,000$-237,000$-299,000$-162,000
    Income Before Tax$-5,316,000$-3,823,000$-1,930,000$-3,377,000$-3,995,000$-3,671,000$-5,173,000$-5,652,000$-10,053,000$-6,714,000$-5,314,000$-3,818,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,316,000$-3,823,000$-1,930,000$-3,377,000$-3,995,000$-3,671,000$-5,173,000$-5,652,000$-10,053,000$-6,714,000$-5,314,000$-3,818,000
    EBITDA$-5,385,000$-3,903,000$-2,010,000$-3,523,000$-4,136,000$-3,795,000$-5,377,000$-5,957,000$-10,211,000$-6,946,000$-5,613,000$-3,974,000
    EBIT$-5,389,000$-3,908,000$-2,015,000$-3,528,000$-4,141,000$-3,799,000$-5,382,000$-5,962,000$-10,217,000$-6,951,000$-5,613,000$-3,980,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MTVA

    News

    Maxim Group Maintains MetaVia(MTVA.US) With Buy Rating, Maintains Target Price $8

    Maxim Group has reiterated its Buy rating on MetaVia (MTVA.US) and maintained its target price at $8. This indicates a continued positive outlook on the company's stock performance from the analytical firm.

    Moomoo•8/19/26•
    Bullish

    MetaVia Inc (MTVA) Earnings Forecast: Future EPS & Revenue Growth Estimates

    MetaVia Inc (MTVA) has a price target of USD 15.50, with analysts forecasting a high of USD 21.00 and a low of USD 3.00. The company's EPS for the previous quarter was USD -0.79, exceeding the market expectation of USD -0.90, and the next quarter's EPS is expected to be USD -0.75. Based on ratings from 2 analysts, the consensus is a "Buy" trend for MTVA stock.

    TradingKey•8/8/26•
    Bullish

    MetaVia Inc. (NASDAQ: MTVA) Share Price, MTVA Stock News, MTVA Share Price & Updates

    This page provides current stock information for MetaVia Inc. (NASDAQ: MTVA), including its stock price, daily range, and recent performance. It also lists several analyst recommendations and news updates related to the company's participation in investor forums and conferences. Financial data such as market capitalization and volume are presented, along with a disclaimer regarding the information's source and purpose.

    Kalkine•8/7/26•
    Neutral

    MetaVia Inc. Q2 2026: Net loss $5.3M, EPS $(0.90) — 10-Q Summary

    MetaVia Inc. reported a net loss of $5.3 million for Q2 2026, with a diluted loss per share of $(0.90), showing an increase in net loss compared to the previous year but an improved EPS. The company also highlighted progress in its clinical pipeline, including advancing studies for vanoglipel and DA-1726, and noted an increase in R&D spending to support these trials. Ongoing operations are financed through recent activities like a public offering and warrant exercises.

    TradingView•8/7/26•
    Neutral

    MTVA: Q2 2026 saw clinical progress and a $5.3M net loss, with cash reserves at $12.6M

    MTVA (MetaVia Inc.) reported significant clinical progress in Q2 2026 for its DA-1726 and vanoglipel programs, with Phase 1 data showing promising weight loss and liver outcomes. Despite a widened net loss of $5.3 million due to increased R&D, the company's cash reserves grew to $12.6 million, sufficient to fund operations through 2027. This information is based on an AI-generated summary of their SEC 8-K Current Report.

    TradingView•8/7/26•
    Neutral

    Frequently Asked Questions About MTVA

    Does MTVA pay dividends?
    MetaVia Inc. (MTVA) does not currently pay a regular dividend.
    What is MTVA's market cap?
    MetaVia Inc. (MTVA) has a market capitalization of $11.20M with a current stock price of $1.72.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In